major
target
neutral
antibodi
nab
reason
import
hiv
immunogen
includ
vaccin
formul
howev
divers
proven
signific
challeng
vaccin
develop
structur
contain
variabl
loop
like
hide
critic
conserv
epitop
site
favour
nab
furthermor
crystallographi
structur
indic
protein
cover
carbohydr
facilit
viral
escap
nab
genet
variabl
group
n
also
affect
induct
nab
factor
complic
design
effect
candid
vaccin
hiv
previou
vaccin
studi
focu
singl
hiv
immunogen
although
studi
show
increas
cell
immun
respons
immunogen
use
abl
induc
potent
nab
mediat
steril
immun
question
remain
singl
immunogen
induc
broad
immun
respons
divers
viru
like
hiv
address
sever
studi
perform
singl
doubl
recombin
protein
use
candid
immunogen
phase
iii
clinic
vaccin
trial
howev
vaccin
effect
protect
hiv
infect
lack
vaccin
efficaci
may
due
hiv
divers
singl
immunogen
neutral
tcell
line
adapt
tcla
strain
none
anim
model
clinic
studi
demonstr
broadli
crossreact
immun
primari
isol
studi
demonstr
neutral
antibodi
respons
primari
isol
howev
measur
crossreact
obtain
strain
hiv
viru
use
nab
assay
contain
use
vaccin
subtyp
b
wide
distribut
throughout
world
common
subtyp
north
america
europ
herein
hypothesis
immun
sever
fourteen
differ
wild
type
subtyp
b
protein
would
increas
breadth
specif
antivir
immun
respons
fourteen
wild
type
subtyp
b
amplifi
clone
recombin
protein
express
mammalian
cell
line
golden
hamster
immun
equival
amount
vs
vs
distinct
protein
humor
antibodi
bind
neutral
cellular
helper
cell
respons
subtyp
b
c
ae
analyz
although
polyval
approach
achiev
modest
increas
breadth
humor
cellular
immun
qualit
chang
vaccin
vs
amount
total
antigen
result
quantit
improv
vaccineinduc
immun
total
rna
purifi
syncytium
nonsyncytium
induc
cocultur
patient
tabl
amplif
product
correspond
full
length
kb
contain
constant
hypervari
region
gener
rtpcr
gene
complet
sequenc
identifi
subtyp
b
amino
acid
sequenc
amplifi
compar
subtyp
b
c
ae
point
mutat
well
insert
delet
mutat
detect
fig
addit
phylogenet
relat
differ
sequenc
hiv
subtyp
b
c
ae
reveal
genet
divers
clone
identifi
fig
due
limit
number
nucleotid
region
algorithm
appli
longitudin
data
set
region
use
neighbor
treemak
fasta
format
approach
epidemiolog
linkag
establish
clone
subtyp
b
c
ae
sequenc
cluster
subtyp
b
isol
mn
isol
epidemiolog
link
subtyp
ae
isol
result
reveal
particular
homolog
clone
subtyp
c
isol
variant
clone
vector
express
purif
recombin
protein
vitro
stabl
cho
cell
line
transfect
construct
select
use
blasticidin
resist
recombin
protein
purifi
metal
affin
chromatographi
express
recombin
protein
determin
western
blot
fig
four
group
hamster
immun
differ
vaccin
formul
indic
tabl
first
group
hamster
immun
mpl
adjuv
alon
second
group
b
hamster
immun
recombin
protein
purifi
patient
number
plu
adjuv
hamster
third
group
c
immun
mixtur
protein
purifi
patient
recombin
protein
adjuv
polyval
group
immun
cocktail
protein
recombin
protein
hamster
immun
subcutan
sc
week
anim
rest
week
boost
week
combin
protein
antibodi
titer
determin
two
week
immun
order
measur
antibodi
titer
variou
protein
plasma
immun
hamster
collect
two
week
immun
analyz
elisa
plate
coat
subtyp
b
mn
c
ae
overnight
follow
incub
serial
dilut
plasma
develop
describ
materi
method
section
first
two
immun
elicit
low
level
antibodi
respons
protein
data
shown
howev
third
immun
antibodi
detect
group
immun
expect
control
group
produc
antibodi
respons
highest
level
antibodi
titer
observ
hamster
immun
recombin
protein
contrast
control
group
adjuv
alon
develop
detect
level
specif
antibodi
respons
eight
week
third
immun
anim
vaccin
respect
recombin
protein
result
similar
third
immun
observ
subtyp
group
polyval
vaccin
group
induc
higher
level
titer
mn
subtyp
b
subtyp
c
ae
fig
result
demonstr
polyval
vaccin
induc
higher
antibodi
respons
subtyp
b
singl
candid
vaccin
two
week
fourth
immun
sera
collect
nab
strain
test
unlik
mani
research
studi
detect
real
breadth
strength
candid
vaccin
use
differ
strain
assay
nab
use
immun
sinc
background
observ
preble
sampl
nab
respons
compar
svamlv
murin
retroviru
envpseudoviru
background
control
nonspecif
activ
group
hamster
receiv
protein
show
higher
nab
titr
mn
strain
singl
p
howev
similar
nab
titr
observ
group
immun
combin
four
protein
fig
sera
immun
hamster
test
primari
isol
none
sera
abl
show
signific
neutral
prolifer
cell
play
import
role
humor
cellular
immun
respons
expans
antigenstimul
b
cell
respect
high
prolif
immun
respons
observ
protein
isol
patient
group
except
control
group
data
shown
howev
assess
measur
strength
candid
vaccin
splenocyt
immun
hamster
stimul
strain
subtyp
includ
vaccin
compon
splenocyt
cultur
presenc
protein
two
day
stimul
thymidin
ad
sixteen
hour
later
cell
harvest
thymidin
incorpor
measur
group
b
c
show
rel
similar
prolif
immun
respons
interestingli
group
hamster
immun
protein
show
highest
lymphocyt
prolif
immun
respons
fig
subtyp
b
mn
c
ae
support
crosssubtyp
activ
th
immun
respons
antigen
variat
major
obstacl
develop
effect
vaccin
nab
mainli
direct
region
play
import
function
bind
viru
either
howev
antigen
hypervari
region
especi
assist
viru
escap
neutral
interestingli
singl
mutat
region
could
chang
viru
viru
shown
monoor
bival
envelop
vaccin
poorli
immunogen
induc
limit
breadth
reactiv
although
nab
shown
control
laboratoryadapt
strain
result
easili
extend
primari
clinic
isol
addit
induc
nab
singl
envelop
studi
lack
crosssubtyp
neutral
activ
could
neutral
strain
hiv
except
strain
contain
vaccin
prepar
interest
studi
zhan
et
al
show
cocktail
envelop
context
dna
vector
recombin
vaccinia
vector
recombin
protein
abl
induc
humor
cellmedi
immun
respons
immun
macaqu
vaccin
macaqu
show
lower
viru
titer
higher
amount
cell
compar
unvaccin
anim
challeng
addit
four
six
vaccin
macaqu
surviv
week
viru
challeng
suggest
multienvelop
vaccin
may
effect
approach
control
infect
increas
breadth
immun
respons
strain
ten
strain
nonsyncytiuminduc
phenotyp
four
syncytiuminduc
phenotyp
select
bank
clinic
isol
although
protein
may
maxim
immun
respons
may
repres
subtyp
b
isol
result
provid
clue
regard
capac
heterolog
subtyp
strain
induc
antivir
immun
respons
recogn
subtyp
multival
approach
increas
breath
immun
respons
heterolog
strain
within
subtyp
could
provid
enhanc
vaccin
protect
within
geograph
region
sequenc
analysi
structur
reveal
despit
vivid
antigen
differ
isol
structur
core
similar
sequenc
strain
analyz
multipl
sequenc
clustalw
align
program
phylogenet
tree
construct
use
neighbor
treemak
evolutionari
histori
cohort
clone
compar
strain
subtyp
differ
subtyp
phylogenet
analysi
confirm
clone
deriv
subtyp
b
protein
express
cho
cell
produc
glycosyl
pattern
similar
one
observ
nativ
structur
form
found
viru
envelop
protein
poorli
express
transient
transfect
cho
cell
solv
problem
stabl
cho
cell
line
creat
product
protein
increas
stabl
cell
line
allow
effici
protein
purif
may
possibl
cocktail
protein
contain
multipl
epitop
abl
maxim
breadth
immun
respons
compar
singl
immunogen
recent
studi
sever
macaqu
prime
dna
encod
subtyp
b
c
boost
recombin
protein
although
strong
cellmedi
immun
respons
induc
potent
neutral
antibodi
respons
detect
anim
far
limit
polyval
vaccin
studi
perform
none
measur
immun
respons
divers
hiv
strain
hand
effect
hiv
vaccin
may
deal
multipl
subtyp
mani
strain
subtyp
interest
note
surfac
envelop
hiv
subtyp
featur
differ
instanc
subtyp
c
enorm
genet
differ
compar
recombin
subtyp
ac
question
aris
whether
immunogen
one
subtyp
effect
subtyp
leandersson
et
al
show
tcell
reactiv
immunogen
subtyp
b
subtyp
hiv
individu
howev
detect
neutral
crossreact
subtyp
anoth
concern
polyval
vaccin
approach
studi
regard
synergist
antagonist
effect
gene
possibl
protein
compon
polyval
vaccin
cocktail
interact
compet
consequ
may
inhibit
downgrad
respons
protein
due
high
background
mice
sera
abl
measur
neutral
antibodi
respons
previou
vaccin
studi
thu
golden
hamster
consid
measur
efficaci
humor
immun
respons
cell
immun
respons
studi
due
nonexist
label
antibodi
hamster
order
analyz
bind
antibodi
titr
plasma
immun
hamster
collect
subtyp
b
mn
c
ae
analyz
separ
elisa
group
receiv
fourteen
protein
show
higher
mean
igg
antibodi
titer
subtyp
b
isol
mn
comparison
group
b
c
result
bind
assay
predict
neutral
serotyp
suggest
antigen
subtyp
may
relat
ident
genet
subtyp
theoret
augment
number
amount
envelop
protein
may
enhanc
control
viremia
follow
infect
number
immunolog
mechan
includ
increas
function
activ
b
cell
promot
neutral
antibodi
crossreact
variou
subtyp
studi
candid
vaccin
abl
neutral
strain
mn
subtyp
interestingli
immun
group
protein
subtyp
b
induc
respons
similar
group
receiv
four
protein
therefor
use
evalu
immunogen
interact
protein
nonhuman
primat
model
result
similar
previous
publish
polyval
studi
neutral
restrict
viru
strain
use
vaccin
polyval
vaccin
abl
neutral
primari
isol
lack
cross
reactiv
nab
result
also
consist
recent
studi
cavacini
et
al
demonstr
quantifi
crosssubtyp
antibodi
reactiv
neutral
subtyp
b
sera
subtyp
c
hiv
viru
anoth
studi
wang
et
al
show
polyval
envelop
protein
approach
abl
induc
neutral
antibodi
respons
howev
polyval
envelop
approach
context
dna
prime
follow
protein
boost
may
abl
neutral
strain
differ
subtyp
patient
face
low
number
cell
differ
stage
diseas
invers
correl
gagspecif
th
cell
rna
plasma
viru
load
shown
strongest
gag
specif
prolif
respons
associ
lower
viral
load
high
viral
load
observ
weak
respons
gag
stimul
lymphocyt
prolifer
assay
test
determin
activ
lymphocyt
encount
protein
differ
subtyp
rel
high
prolif
immun
respons
determin
subtyp
b
c
ae
group
hamster
immun
fourteen
protein
subtyp
b
group
develop
stimul
indic
four
fold
baselin
subtyp
result
consist
currier
jr
et
al
show
comprehens
crosssubtyp
reactiv
cellmedi
immun
respons
individu
differ
subtyp
summari
polyval
candid
vaccin
deriv
subtyp
b
abl
neutral
primari
isol
howev
substanti
proport
crosssubtyp
reactiv
observ
polyval
group
subtyp
b
c
ae
virus
isol
hivinfect
individu
visit
hiv
clinic
ottawa
hospit
verbal
consent
obtain
hiv
patient
particip
studi
briefli
isol
viru
perform
place
peripher
blood
mononuclear
cell
pbmc
iscov
modifi
dulbecco
medium
imdm
sigma
st
loui
mo
supplement
fetal
calf
serum
fc
life
technolog
grand
island
ny
mm
glutamin
sigma
gentamicin
sigma
equal
number
phytohemagglutinin
pha
sigma
stimul
donor
cell
cell
incub
contain
iuml
r
system
minneapoli
mn
ad
increas
growth
cell
cocultur
maintain
week
period
media
chang
freshli
stimul
donor
cell
ad
everi
day
sustain
hiv
replic
virus
measur
supernat
hiv
antigen
kit
dupont
wilmington
de
total
rna
purifi
use
rneasi
extract
kit
qiagen
mississauga
syncytium
nonsyncytium
induc
subtyp
b
cocultur
encod
sequenc
kb
amplifi
rtpcr
amplicon
purifi
use
qiaquick
gel
extract
kit
qiagen
mississauga
clone
pcr
topota
vector
invitrogen
burlington
plasmid
digest
kb
band
correspond
gene
subclon
vector
invitrogen
design
overproduct
recombin
protein
mammalian
cell
line
system
recombin
protein
may
purifi
affin
chromatographi
use
cmyc
epitop
poli
histidin
metalbind
tag
express
construct
confirm
character
restrict
enzym
nucleotid
sequenc
analysi
fourteen
region
align
use
clustalw
multipl
sequenc
align
program
dna
protein
end
sequenc
also
manual
adjust
phylogenet
tree
construct
neighbor
treemak
hiv
sequenc
databas
program
convert
sequenc
align
fasta
format
cho
cell
grown
imdm
sigma
supplement
fc
life
technolog
uml
penicillin
gentamicin
sigma
cho
cell
transfect
vector
express
structur
gene
stabl
cell
line
establish
use
blasticidinesuppl
medium
cell
harvest
sonic
lyse
lysi
buffer
mm
tri
base
mm
mercaptoethanol
cocktail
proteas
inhibitor
recombin
viral
protein
purifi
talon
metal
resin
kit
clontech
palo
alto
ca
per
manufactur
instruct
recombin
protein
confirm
western
blot
immunofluorec
antibodi
stain
previous
describ
sixweek
old
golden
hamster
purchas
jackson
laboratori
bar
harbor
hamster
maintain
accord
laboratori
standard
procedur
hous
anim
care
faculti
medicin
univers
ottawa
total
recombin
protein
mg
monophosphoryl
lipid
mpl
corixa
hamilton
mt
inject
per
anim
group
four
hamster
immun
four
time
subcutan
sc
three
differ
site
one
month
interv
immun
fourteen
day
last
boost
hamster
sacrif
spleen
blood
collect
test
longterm
storag
cryopreserv
medium
elisa
plate
coat
overnight
protein
clade
b
mn
c
ae
obtain
aid
research
refer
reagent
program
nation
institut
allergi
infecti
diseas
niaid
plate
wash
pb
contain
tween
block
h
bsa
pb
follow
second
wash
tween
plate
incub
h
serial
dilut
sera
plate
wash
incub
h
peroxidaseconjug
affinitypurifi
rabbit
antihamst
secondari
antibodi
biorad
wash
color
develop
ophenylendiamin
dihydrochlorid
opd
sigma
st
louis
mo
color
reaction
stop
n
hcl
absorb
read
nm
elisa
plate
reader
biorad
neutral
measur
function
reduct
luciferas
report
gene
express
singl
round
infect
tzmbl
cell
tzmbl
cell
obtain
nih
aid
research
refer
reagent
program
contribut
john
kapp
xiaoyun
wu
briefli
viru
incub
serial
dilut
serum
sampl
triplic
total
volum
hr
flatbottom
cultur
plate
freshli
trypsin
tzmbl
cell
cell
growth
medium
contain
deae
dextran
ad
well
indinavir
ad
final
concentr
prevent
viru
replicaton
case
mn
one
set
control
well
receiv
cell
viru
viru
control
anoth
set
receiv
cell
background
control
hour
incub
cell
transfer
black
solid
plate
corn
costar
rochest
ny
measur
luminesc
use
bright
glo
substrat
solut
describ
supplier
promega
madison
wi
assay
stock
mn
prepar
cell
assay
stock
envpseudotyp
virus
prepar
tranfect
cell
viru
stock
made
cellfre
filtrat
store
use
assay
perform
thymidin
incorpor
previous
describ
briefli
splenocyt
immun
hamster
resuspend
cellsml
rpmi
contain
fc
uml
penicillinstreptomycin
aliquot
contain
cell
ad
well
well
plate
protein
subtyp
b
c
ae
ad
well
triplic
posit
control
cell
also
stimul
phorbol
ionomycin
pmaion
sigma
h
cultur
thymidin
amersham
arlington
height
il
ad
well
follow
h
incub
cell
harvest
onto
glass
fibr
filtermat
thymidin
incorpor
measur
microbeta
beta
counter
wallac
turku
finland
nab
neutral
antibodi
cho
chines
hamster
ovari
aa
perform
analyz
major
experi
particip
design
wrote
manuscript
dea
particip
analyz
data
mg
help
clone
kg
revis
paper
critic
fdm
particip
design
coordin
studi
help
draft
final
manuscript
author
read
approv
final
manuscript
